Fludeoxyglucose (18F)
- Generic Name
- Fludeoxyglucose (18F)
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C6H11FO5
- CAS Number
- 63503-12-8
- Unique Ingredient Identifier
- 0Z5B2CJX4D
- Background
Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing no-carrier added radioactive 2-deoxy-2-[18F]fluoro-D-g1ucose, which is used for diagnostic purposes in conjunction with Positron Emission Tomography (PET). It is administered by intravenous injection.
- Indication
The uptake of 18F-FDG by tissues is a marker for the tissue uptake of glucose, which in turn is closely correlated with certain types of tissue metabolism.
Fludeoxyglucose F 18 Injection is indicated in positron emission tomography (PET) imaging for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnoses of cancer.
- Associated Conditions
- Cancer, Coronary Artery Disease (CAD), Epileptic seizure, Left Ventricular Dysfunction
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.